Osmotic Laxative
Pregnancy: Compatible — macrogol not absorbed; preferred osmotic laxative in pregnancy after lactulose.
Macrogol (Polyethylene Glycol)
Brand names: Movicol, Laxido, CosmoCol
Adult dose
Dose: Constipation: 1–3 sachets dissolved in 125mL water each, taken daily (adjust to produce comfortable stool). Faecal impaction: 8 sachets dissolved in 1 litre water, taken over 6 hours daily for up to 3 days.
Route: Oral
Frequency: Daily (constipation) or up to 8 sachets/day in 3 days (impaction)
Max: 8 sachets/day (impaction, max 3 days); 3 sachets/day (chronic constipation)
Each Movicol/Laxido sachet contains macrogol 3350 (13.125g) + electrolytes. Dissolve in water — do not take dry. Onset 24–48 hours. Preferred laxative in faecal impaction (NICE NG128). Faecal impaction regimen: 8 sachets/day for 3 days — ensure patient can tolerate fluid load (heart failure risk).
Paediatric dose
Route: Oral
Frequency: Daily
Max: 4 sachets/day (children 2–11 years)
BNF for Children: Movicol Paediatric Plain sachets (6.9g macrogol per sachet). Constipation: 2–5 years: 1 sachet/day; 6–11 years: 2 sachets/day (increase to max 4 sachets/day if needed). Faecal impaction 5–11 years: 4 sachets day 1, increasing by 2 per day to max 12/day if needed. 12–17 years: adult dose. Source: BNF for Children 2024; NICE NG128.
Dose adjustments
Renal
Caution in severe renal impairment — electrolyte content of each sachet may accumulate.
Hepatic
No dose adjustment required.
Clinical pearls
- NICE NG128 (Faecal impaction): macrogol (Movicol) is first-line — superior to stimulant laxatives for impaction treatment.
- Faecal impaction 8-sachet regimen: over 6 hours daily for 3 days. Warn patient of loose stool. Review after 3 days — if no response, consider manual evacuation under anaesthesia.
- Long-term use for chronic constipation: well tolerated and effective. No evidence of tolerance or dependence.
- Caution with faecal impaction regimen in heart failure — 1 litre/day extra fluid may precipitate decompensation.
Contraindications
- Intestinal obstruction or perforation
- Ileus
- Toxic megacolon
- Severe inflammatory bowel disease
Side effects
- Abdominal distension and bloating (common, especially impaction dose)
- Nausea
- Diarrhoea (if overused)
- Electrolyte disturbance (with high doses — rare)
- Fluid overload (high dose in cardiac failure)
Interactions
- No significant drug interactions (not absorbed)
Monitoring
- Stool frequency and consistency
- Hydration
- Electrolytes (high dose/impaction regimen)
- Fluid balance (cardiac risk patients)
Reference: BNFc; BNF 90; NICE NG128 Constipation; NICE CG99 Constipation in Children; SPC Movicol. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021